Cancer
Research conducted by Wuyi University has led to a breakthrough in detecting microsatellite instability (MSI) in cancer using multiplexed orthogonal gap-enhanced Raman tags (O-GERTs). A team of scientists, led by Rihui Wu, developed four orthogonal O-GERT flavors with high sensitivity and spectral resolution, allowing for one-shot detection of four mismatch
Cancer
Cancer researchers have made significant strides in understanding the role of tumor-infiltrating lymphocytes (TILs) in cancer immunotherapy. TILs are a diverse population of immune cells that play a crucial role in tumor immunity. A recent study published in Frontiers in Immunology has explored the phenotypic and functional diversity of TILs,
Cancer
Researchers at New York University (NYU) have made significant progress in cancer gene therapy using a Sindbis viral (SV) vector platform. A new study published in the journal Pharmaceuticals has shown promising results in treating pancreatic cancer, a highly immunosuppressive and challenging disease. The study aimed to assess the treatment
Cancer
Cancer survivors often experience significant financial hardship due to the rising costs of novel immunotherapies, making it challenging for them to afford medical care. A recent study published in the Journal of Cancer Survivorship has examined the association between financial hardship and receipt of high-cost immunotherapy among cancer survivors. The
Cancer
A recent study published in BMC Cancer has revealed that immunotherapy treatment in patients with COVID-19 does not increase the risk of 30-day mortality. The study, conducted by researchers at Western University, analyzed data from Ontario, Canada, and found that 22% of patients who received immunotherapy treatment within 120 days
Cancer
Research has made a significant breakthrough in the field of cancer gene therapy with the development of a cyclodextrin-based drug delivery system. This novel approach has the potential to overcome the limitations of existing oncotherapies, which are often hindered by low solubility and poor bioavailability. The study, published in the
Cancer
Researchers at Memorial Sloan-Kettering Cancer Center have made a significant discovery in the field of gene therapy. By investigating the anti-tumor response in the leptomeninges, a cerebrospinal fluid-filled space surrounding the brain and spinal cord, the team has identified a unique role for interferon-g (IFN-g) in controlling cancer cell growth.
Cancer
As the COVID-19 pandemic unfolded, it brought with it unprecedented challenges and hardships for families worldwide. For one family, the impact was particularly severe. When their father was diagnosed with stage four non-Hodgkin lymphoma in January 2021, their world was turned upside down. With six months of chemotherapy ahead, their
Cancer
A new study published in the Annals of Gastroenterological Surgery has highlighted significant progress in the treatment of gastric cancer, a major global health burden, particularly in East Asia. Researchers at the University of Yamanashi have summarized key updates from 2023 to 2024, focusing on surgical innovations, perioperative systemic therapy,
Cancer
Research from Sun Yat-sen University has led to the development of a double-lock protected PtII nanomedicine that has shown significant potential in treating cancer. This breakthrough has been achieved by creating a nanomedicine that releases active platinum species only in the presence of cancer cells, thereby minimizing side effects and
Cancer
Fresh data on gastric cancer have been presented in a new report from the Sun Yat-Sen University Cancer Center. Research on the efficacy of PD-1 inhibitors for metastatic gastric cancer after progression on previous chemoimmunotherapy has shed light on the benefits of continuing immunotherapy. The study found that patients who
Cancer
DelveInsight's HER2+ Gastric Cancer Market report provides a comprehensive understanding of current treatment practices, emerging HER2+ gastric cancer therapies, market share of individual therapies, and current and forecasted HER2+ gastric cancer market size from 2020 to 2034, segmented into 7MM (the United States, the EU4, the United Kingdom,
